8-K

Company

Calidi Biotherapeutics, Inc.

Filed

October 31, 2025

Period of Report

October 27, 2025

Accession Number

0001493152-25-020390

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →